Reprogenesis Inc.
This article was originally published in Start Up
Executive Summary
Tissue Engineering. With three core technologies, Reprogenesis has the ability to build in, paint on or inject cell matrices to support tissue growth in a wide variety of applications. The company will focus on urology, plastic and reconstructive surgery, orthopedics and cardiovascular applications. The company is initially working on an enduring treatment for stress incontinence and vesicoureteral reflux, as well as two technologies for breast reconstruction.